Search

Your search keyword '"Van Deerlin, V"' showing total 177 results

Search Constraints

Start Over You searched for: Author "Van Deerlin, V" Remove constraint Author: "Van Deerlin, V"
177 results on '"Van Deerlin, V"'

Search Results

2. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

3. New insights into the genetic etiology of Alzheimer's disease and related dementias

4. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

5. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

7. Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.

8. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

9. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

10. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

11. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

12. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

13. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

17. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease.

21. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

22. Nat Genet

23. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

24. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

25. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing

26. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

27. CXCR4involvement in neurodegenerative diseases

28. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum

29. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

30. Analysis of shared heritability in common disorders of the brain

31. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

32. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

33. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

34. Immune-related genetic enrichment in frontotemporal dementia

35. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases

36. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia

37. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

38. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

39. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

40. Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type

41. Erratum exome sequencing reveals VCP mutations as a cause of familial ALS

43. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease

44. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

45. Clinical and pathological continuum of multisystem TDP-43 proteinopathies

46. Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.

48. Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit

49. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration

Catalog

Books, media, physical & digital resources